NATURAL ALTERNATIVES INTERNATIONAL INC Revenue, Net (Deprecated 2018-01-31)
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported Revenue, Net (Deprecated 2018-01-31) of $33.34 million for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-02-13.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-02-13
- NATURAL ALTERNATIVES INTERNATIONAL INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $33.34M, a 9.08% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $28.07M, a 17.59% decline year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $32.19M, a 9.84% decline year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $25.14M, a 16.23% decline year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC revenue, net (deprecated 2018-01-31) for fiscal 2017 was $121.95M, a 6.78% increase from fiscal 2016.
- NATURAL ALTERNATIVES INTERNATIONAL INC revenue, net (deprecated 2018-01-31) for fiscal 2016 was $114.20M, a 43.63% increase from fiscal 2015.
- NATURAL ALTERNATIVES INTERNATIONAL INC revenue, net (deprecated 2018-01-31) for fiscal 2015 was $79.51M, a 7.53% increase from fiscal 2014.
- NATURAL ALTERNATIVES INTERNATIONAL INC revenue, net (deprecated 2018-01-31) for fiscal 2014 was $73.94M, a 17.75% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $33.34M 10-Q · filed 2018-02-13 | $61.41M 10-Q · filed 2018-02-13 | $93.59M derived: sum of 3 quarters · filed 2018-02-13 | $118.73M derived: sum of 4 quarters · filed 2018-02-13 |
| 2017-09-30 | $28.07M 10-Q · filed 2017-11-13 | $60.26M derived: sum of 2 quarters · filed 2017-11-13 | $85.39M derived: sum of 3 quarters · filed 2017-11-13 | $115.95M derived: sum of 4 quarters · filed 2018-02-13 |
| 2017-06-30 | $32.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-18 | $57.32M derived: sum of 2 quarters · filed 2017-09-18 | $87.88M derived: sum of 3 quarters · filed 2018-02-13 | $121.95M 10-K · filed 2017-09-18 |
| 2017-03-31 | $25.14M 10-Q · filed 2017-05-15 | $55.69M derived: sum of 2 quarters · filed 2018-02-13 | $89.76M 10-Q · filed 2017-05-15 | $125.46M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-12-31 | $30.56M 10-Q · filed 2018-02-13 | $64.63M 10-Q · filed 2018-02-13 | $100.33M derived: sum of 3 quarters · filed 2018-02-13 | $130.33M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-09-30 | $34.07M 10-Q · filed 2017-11-13 | $69.77M derived: sum of 2 quarters · filed 2017-11-13 | $99.77M derived: sum of 3 quarters · filed 2017-11-13 | $126.68M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $35.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-18 | $65.70M derived: sum of 2 quarters · filed 2017-09-18 | $92.62M derived: sum of 3 quarters · filed 2017-09-18 | $114.20M 10-K · filed 2017-09-18 |
| 2016-03-31 | $30.01M 10-Q · filed 2017-05-15 | $56.92M derived: sum of 2 quarters · filed 2017-05-15 | $78.50M 10-Q · filed 2017-05-15 | $101.08M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $26.91M 10-Q · filed 2017-02-14 | $48.50M 10-Q · filed 2017-02-14 | $71.08M derived: sum of 3 quarters · filed 2017-02-14 | $90.69M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-09-30 | $21.59M 10-Q · filed 2016-11-07 | $44.17M derived: sum of 2 quarters · filed 2016-11-07 | $63.78M derived: sum of 3 quarters · filed 2016-11-07 | $82.40M derived: sum of 4 quarters · filed 2016-11-07 |
| 2015-06-30 | $22.58M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-19 | $42.20M derived: sum of 2 quarters · filed 2016-09-19 | $60.81M derived: sum of 3 quarters · filed 2016-09-19 | $79.51M 10-K · filed 2016-09-19 |
| 2015-03-31 | $19.61M 10-Q · filed 2016-05-10 | $38.23M derived: sum of 2 quarters · filed 2016-05-10 | $56.93M 10-Q · filed 2016-05-10 | $78.11M derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | $18.62M 10-Q · filed 2016-02-09 | $37.31M 10-Q · filed 2016-02-09 | $58.50M derived: sum of 3 quarters · filed 2016-02-09 | $77.63M derived: sum of 4 quarters · filed 2016-02-09 |
| 2014-09-30 | $18.70M 10-Q · filed 2015-11-12 | $39.88M derived: sum of 2 quarters · filed 2015-11-12 | $59.01M derived: sum of 3 quarters · filed 2015-11-12 | $75.48M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $21.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-18 | $40.31M derived: sum of 2 quarters · filed 2015-09-18 | $56.79M derived: sum of 3 quarters · filed 2015-09-18 | $73.94M 10-K · filed 2015-09-18 |
| 2014-03-31 | $19.13M 10-Q · filed 2015-05-12 | $35.60M derived: sum of 2 quarters · filed 2015-05-12 | $52.76M 10-Q · filed 2015-05-12 | $69.57M derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | $16.48M 10-Q · filed 2015-02-12 | $33.63M 10-Q · filed 2015-02-12 | $50.45M derived: sum of 3 quarters · filed 2015-02-12 | $66.28M derived: sum of 4 quarters · filed 2015-02-12 |
| 2013-09-30 | $17.16M 10-Q · filed 2014-11-12 | $33.97M derived: sum of 2 quarters · filed 2014-11-12 | $49.81M derived: sum of 3 quarters · filed 2014-11-12 | $63.49M derived: sum of 4 quarters · filed 2014-11-12 |
| 2013-06-30 | $16.82M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-25 | $32.65M derived: sum of 2 quarters · filed 2014-09-25 | $46.34M derived: sum of 3 quarters · filed 2014-09-25 | $62.80M 10-K · filed 2014-09-25 |
| 2013-03-31 | $15.84M 10-Q · filed 2014-05-13 | $29.52M derived: sum of 2 quarters · filed 2014-05-13 | $45.98M 10-Q · filed 2014-05-13 | $66.88M derived: sum of 4 quarters · filed 2014-05-13 |
| 2012-12-31 | $13.69M 10-Q · filed 2013-02-12 | $30.15M 10-Q · filed 2014-02-12 | $51.04M derived: sum of 3 quarters · filed 2014-02-12 | $68.47M derived: sum of 4 quarters · filed 2014-02-12 |
| 2012-09-30 | $16.46M 10-Q · filed 2013-11-13 | $37.36M derived: sum of 2 quarters · filed 2013-11-13 | $54.78M derived: sum of 3 quarters · filed 2013-11-13 | $70.94M derived: sum of 4 quarters · filed 2013-11-13 |
| 2012-06-30 | $20.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-19 | $38.32M derived: sum of 2 quarters · filed 2013-09-19 | $54.48M derived: sum of 3 quarters · filed 2013-09-19 | $72.82M 10-K · filed 2013-09-19 |
| 2012-03-31 | $17.42M 10-Q · filed 2012-05-14 | $33.58M derived: sum of 2 quarters · filed 2013-05-14 | $51.92M 10-Q · filed 2013-05-14 | $66.32M derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | $16.16M 10-Q · filed 2013-02-12 | $34.50M 10-Q · filed 2013-02-12 | $48.90M derived: sum of 3 quarters · filed 2013-02-12 | $62.27M derived: sum of 4 quarters · filed 2013-02-12 |
| 2011-09-30 | $18.34M 10-Q · filed 2012-11-14 | $32.74M derived: sum of 2 quarters · filed 2012-11-14 | $46.11M derived: sum of 3 quarters · filed 2012-11-14 | $60.87M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-21 | $27.77M derived: sum of 2 quarters · filed 2012-09-21 | $42.53M derived: sum of 3 quarters · filed 2012-09-21 | $55.88M 10-K · filed 2012-09-21 |
| 2011-03-31 | $13.38M 10-Q · filed 2012-05-14 | $28.13M derived: sum of 2 quarters · filed 2012-05-14 | $41.48M 10-Q · filed 2012-05-14 | |
| 2010-12-31 | $14.75M 10-Q · filed 2012-02-13 | $28.11M 10-Q · filed 2012-02-13 | ||
| 2010-09-30 | $13.36M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |